These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2772864)

  • 1. Studies on antithrombotic effects of recombinant hirudin.
    Markwardt F; Kaiser B; Nowak G
    Thromb Res; 1989 Jun; 54(5):377-88. PubMed ID: 2772864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparin.
    Doutremepuich C; Deharo E; Guyot M; Lalanne MC; Walenga J; Fareed J
    Thromb Res; 1989 Jun; 54(5):435-45. PubMed ID: 2772867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects of recombinant hirudin in different animal models.
    Just M; Tripier D; Seiffge D
    Haemostasis; 1991; 21 Suppl 1():80-7. PubMed ID: 1716605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
    Krupinski K; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():88-92. PubMed ID: 1894199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic action of recombinant hirudin in a venous thrombosis model.
    Raake W; Klauser RJ; Elling H; Zeiller P
    Haemostasis; 1991; 21 Suppl 1():127-32. PubMed ID: 1654293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis.
    Biemond BJ; Friederich PW; Levi M; Vlasuk GP; Büller HR; ten Cate JW
    Circulation; 1996 Jan; 93(1):153-60. PubMed ID: 8616922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis model.
    Doutremepuich C; Lalanne MC; Doutremepuich F; Walenga J; Fareed J; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():99-106. PubMed ID: 1894201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
    Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP
    Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
    Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M; Nurmohamed M; Kienast J; Siebeck M; Silling-Engelhardt G; Büller H; Hoet B; Bichler J; Close P
    J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models.
    Bacher P; Walenga JM; Iqbal O; Bajusz S; Breddin K; Fareed J
    Thromb Res; 1993 Aug; 71(4):251-63. PubMed ID: 8236155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirudin in disseminated intravascular coagulation.
    Nowak G; Markwardt F
    Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting.
    Bode C; Hanson SR; Schmedtje JF; Haber E; Mehwald P; Kelly AB; Harker LA; Runge MS
    Circulation; 1997 Feb; 95(4):800-4. PubMed ID: 9054733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effects of recombinant hirudin in experimental angioplasty and intravascular thrombolysis.
    Kaiser B; Simon A; Markwardt F
    Thromb Haemost; 1990 Feb; 63(1):44-7. PubMed ID: 2140204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
    Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
    J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subcutaneous recombinant hirudin in the treatment of deep venous thrombosis. A pharmacokinetic study].
    Schiele F; Vuillemenot A; Mouhat T; Kramarz P; Kieffer Y; Camez A; Bassand JP
    Arch Mal Coeur Vaiss; 1995 Mar; 88(3):329-35. PubMed ID: 7487286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant hirudin and its analogs--new perspectives in antithrombotic treatment].
    Lewandowski K; Zawilska K
    Pol Arch Med Wewn; 1992 Nov; 88(5):273-9. PubMed ID: 1300546
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins.
    Zhang B; Wieslander JB
    Microsurgery; 1996; 17(2):89-96. PubMed ID: 8914063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.